Search for: "Astra Zeneca Pharmaceutical Company" Results 21 - 30 of 30
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
5 May 2021, 9:34 am by Kluwer Patent blogger
As the BBC commented in an analysis: “Unlike rivals Astra Zeneca and Johnson & Johnson which vowed to forego profits on the vaccine during the pandemic, Pfizer planned to make money on its vaccines. [read post]
27 Jan 2021, 1:44 pm by Kevin LaCroix
After the coronavirus outbreak became widespread in early 2020, AstraZeneca was one of several pharmaceutical companies to become involved in efforts to develop a COVID-19 vaccine. [read post]
5 May 2021, 9:34 am by Kluwer Patent blogger
” According to Gates, pharmaceutical companies are not refusing to share COVID-19 vaccine formulas. [read post]
27 Mar 2009, 8:00 am
(Intellectual Property Watch) Two final thoughts on big pharma acquisitions (IP finance) Brazil: Patent term cutbacks in Brazil and pharmaceutical pipelines – IP Think Tank podcast 23 March 2009 (IP Think Tank) Brazil: Patent term cutbacks - Lobbying, intellectual property and superior courts (IP Think Tank) Brazil: Patent term extension (PTE) under TRIPs revisited and reviewed by Superior Court of Justice (IP tango) Denmark: Harmonisation in Denmark: Patents covering… [read post]
8 Oct 2020, 7:26 am by Michael Geist
Years of publicly funded research has been essential in supporting the race to find an effective COVID-19 vaccine, serving as the foundation for the Astra-Zeneca/Oxford vaccine candidate. [read post]
17 Feb 2010, 5:10 am
(IP Whiteboard) EU: European Commission probes for evidence of foul play among pharmaceutical companies (IP Whiteboard) EU / UK: Of conflict and cooperation: when national courts and the EPO differ: Eli Lilly and Company v Human Genome Sciences (PatLit) India: Drug makers decry Indian patent law (GenericsWeb) India: India-EU gets flak in India (GenericsWeb) India: Delhi High Court: Rejection of application based on pre-grant representation may be appealed to IPAB: UCB… [read post]
6 Apr 2022, 6:35 am by The Petrie-Flom Center Staff
For example, although Astra Zeneca did not aim to maximize profits at the beginning of the pandemic, it declared low-cost pricing for its COVID-19 vaccine to be over before the Omicron wave started. [read post]
14 Apr 2021, 6:49 am by Matthieu Dhenne (Ipsilon)
Similarly, Oxford University holds patents on the recombinant DNA technology used in Astra Zeneca’s vaccine, to which Oxford University has granted an exclusive license[4]. [read post]
2 Jun 2011, 12:46 pm by Bexis
Ortho Pharmaceutical Corp., 681 P.2d 1038, 1052 (Kan. 1984). [read post]